Statement by Sr. Mary Haddad, RSM, President and Chief Executive Officer,
Catholic Health Association of the United States
“The Catholic Health Association of the United States (CHA) is encouraged by reports that a COVID-19 vaccine developed by Pfizer and BioNTech is being submitted for emergency utilization approval by the U.S. Food and Drug Administration and another produced by Moderna is not far behind.
“Because COVID-19 has had a disproportionate impact on vulnerable populations, such as the elderly, low-income communities, persons with pre-existing health conditions, and racial and ethnic minorities, CHA believes it is essential that any approved COVID-19 vaccine be distributed in a coordinated and equitable manner.
“In addition, using the guidelines released by the Vatican’s Pontifical Academy for Life in 2005 and 2017 on the origin of vaccines, CHA ethicists, in collaboration with other Catholic bioethicists, find nothing morally prohibitive with the vaccines developed by Pfizer and BioNTech and Moderna. CHA encourages Catholic health organizations to distribute the vaccines developed by these companies.
“CHA applauds the work of the scientists who have developed these vaccines in a manner consistent with human dignity and will work to support efforts to educate the public about the importance of getting vaccinated.”
The Catholic Health Association of the United States is the national leadership organization of the Catholic health ministry, representing the largest nonprofit provider of health care services in the nation.
» Download PDF
- 1 in 7 patients in the U.S. is cared for in a Catholic hospital each day.
- Catholic health care, which includes more than 2,200 hospitals, nursing homes, long-term care facilities, systems, sponsors, and related organizations, serves the full continuum of health care across our nation.